ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Rall Says NTP to Put 50-75 Chemicals On Long Term Tests

January 19, 1979

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

In Brief: NCI Reorganization Announcement Coming Up; No Decisions On Organ Site, Center Programs NCI Reorganization

May 12, 1978

DCE Board Approves Concept For 14-19 New Grants, Four New Contracts

November 4, 1988

Funding opportunities listed.

April 23, 2004